Mesabi Trust Press Releases

MSB 
$20.43
*  
0.88
4.5%
Get MSB Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading MSB now
Exchange: NYSE
Industry: Basic Industries
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Mesabi Trust Declares Distribution
10/14/2014 5:21:00 PM - Business Wire
▲14.26 % Price Change since this news event. The Volume Ratio is 1.46.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mesoblast Partner JCR Pharmaceuticals Files for Marketing Approval of the First Allogeneic Stem Cell Product in Japan
9/30/2014 8:17:00 PM - GlobeNewswire


Mesoblast Partner JCR Pharmaceuticals Files for Marketing Approval of the First Allogeneic Stem Cell Product in Japan
9/30/2014 8:17:00 PM - GlobeNewswire


Mesoblast Unveils Path to Bring Its Key Products to Market
8/25/2014 8:27:00 PM - GlobeNewswire


Pharmaceutical Executive Joins Mesoblast As Chief Financial Officer
8/24/2014 9:16:00 PM - GlobeNewswire


National Institutes of Health and Mesoblast Enter Into Agreement for 120-Patient Trial In End-Stage Heart Failure
8/6/2014 8:57:00 PM - GlobeNewswire